Study directory

Depression studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
6115studies shown
Showing 3,769-3,780 of 6,115
Behavioral study icon
Not recruitingISRCTN55681753

Wait Less; an online brief psychological intervention to reduce waiting list distress

This study is looking at whether cognitive behavioural therapy can help people with Depression in young people aged 12 to 17 years or Mental and Behavioural Disorders. Participants receive a study treatment and complete follow-up visits and assessments.

In United Kingdom
Why is this study shown?

This study is directly about Depression.

DepressionOtherFrom 12 Years to 17 Years
Countries
United Kingdom
Sponsor
University of Cambridge
Condition
Depression
Drug study icon
TerminatedEUCTR 2011-001692-39

A 21-week, multicenter, open label study to evaluate the safety and tolerability profile of the combination of a SSRI or SNRI antidepressive therapy with oral fingolimod in the treatment of RRMS pa...

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Germany
Why is this study shown?

This study is directly about Depression.

DepressionDrugA study involving a medication or substance.
Countries
Germany
Sponsor
Novartis Pharma GmbH
Condition
Depression
Drug study icon
CompletedEUCTR 2015-004210-26

A Phase IV double blind multi-site, individually randomised parallel group controlled trial investigating the use of citalopram, sertraline, fluoxetine and mirtazapine in preventing relapse in pati...

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In United Kingdom
Why is this study shown?

This study is directly about Depression.

DepressionDrug
Countries
United Kingdom
Sponsor
PRIMENT Clinical Trials Unit, UCL
Condition
Depression
Drug study icon
TerminatedEUCTR 2012-001357-10

A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Once a Day, TAK-375 (Ramelteon) Tablet for Sublingual Administration (TAK-375SL Tablet) 0.1 mg a...

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Bulgaria
Why is this study shown?

This study is directly about Depression.

Depression, BipolarityDrug
Countries
United Kingdom, Bulgaria, Czechia, ...
Sponsor
Takeda Global Research & Development Centre (Europe) Ltd (TGRD)
Condition
Depression, Bipolarity
Drug study icon
CompletedEUCTR 2004-004909-16

An International, Multi-centre, Double-blind, Randomised, Parallel-group, Placebo-controlled, Phase III study of the Efficacy and Safety of Quetiapine Fumarate (Seroquel™, single oral 300 mg or 600...

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In United Kingdom
Why is this study shown?

This study is directly about Depression.

Depression, BipolarityDrug
Countries
United Kingdom
Sponsor
AstraZeneca AB
Condition
Depression, Bipolarity
Drug study icon
CompletedEUCTR 2012-004509-29

Antidepressant treatments during pregnancy and lactation: prediction of drug exposure through breastfeeding and evaluation of drug effect on the neonatal adaptation and the development of the youn...

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In France
Why is this study shown?

This study is directly about Depression.

DepressionDrug
Countries
France
Sponsor
Hospices Civils de Lyon
Condition
Depression
Biological study icon
CompletedEUCTR 2008-001417-26

Double blind, randomized, placebo-controlled, mulitcentric clinical trial to evaluate the relapse prevention of a hypericum extract in outdoor patients with moderate depressive episodes (major depr...

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Germany
Why is this study shown?

This study is directly about Depression.

DepressionBiological
Countries
Germany
Sponsor
Steigerwald Arzneimittelwerk GmbH
Condition
Depression
Drug study icon
CompletedEUCTR 2018-002901-68

Double-blind, controlled, randomized phase 2 study of efficacy, safety, pharmacokinetics and pharmacodynamics of a daily oral administration of MAP4343 during 6 weeks in antidepressant-non responde...

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In France
Why is this study shown?

This study is directly about Depression.

DepressionDrug
Countries
France
Sponsor
MAPREG
Condition
Depression
Biological study icon
CompletedEUCTR 2006-003717-41

EVALUATE THE TOLERABILITY AND EFFICACY OF OMEGA 3 ON MOOD ANDMOTOR SYMPTOMS OF PATIENTS SUFFERING FROM PARKINSON DISEASE

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Italy
Why is this study shown?

This study is directly about Depression.

DepressionBiological
Countries
Italy
Sponsor
POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI
Condition
Depression
Drug study icon
TerminatedEUCTR 2022-001824-13

Influence of oxycodone on individuals taking an SSRI

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Netherlands
Why is this study shown?

This study is directly about Depression.

DepressionDrug
Countries
Netherlands
Sponsor
Leiden University Medical Center
Condition
Depression
Drug study icon
CompletedEUCTR 2017-005100-99

Pharmacoepidemiology and pharmacogenetics of antidepressant treatment for depressive disorders (PEGAD)

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Finland
Why is this study shown?

This study is directly about Depression.

DepressionDrug
Countries
Finland
Sponsor
Helsinki University and University Hospital
Condition
Depression
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.